Neoadjuvant treatment with gemcitabine and S1

2 trials

Sponsors

Department of surgery, Tohoku University, Study group of preoperative therapy for pancreatic cancer (Prep)

Conditions

resectable pancreatic cancer

Phase 2

Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma

Active, not recruitingJPRN-UMIN000001504

Department of surgery, Tohoku Universityresectable pancreatic cancer

Start: 2008-11-01Target: 30Updated: 2026-06-29

Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 for resectable pancreatic carcinoma

Active, not recruitingJPRN-UMIN000004148

Study group of preoperative therapy for pancreatic cancer (Prep)resectable pancreatic cancer

Start: 2010-10-01Target: 80Updated: 2026-06-29

Related Papers

A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.

2018-09-0463 citations